An international group of some of the world’s largest pharmaceutical companies gathered to improve the detection of drug side effects. The drug safety research group (DSRU) has established an international group consisting of pharmaceutical giants such as Pfizer, Roche, BMS, Takeda, Lilly, Gilead, Alexion and Celgene to explore the best ways to detect side effects from licensed drugs.
US regulators have accepted an application of Allergan to market ubrogepant for the acute treatment of migraine. The Dublin, a group headquartered in Ireland, says it hopes the drug will be the first oral CGRP receptor antagonist approved to treat this condition.
Millions of people in the UK may be putting their health at risk because they don’t know how to check the safety of the drugs they bought online according to the results of a new survey.
The US Food and Drug Administration (FDA) has approved Spravato (esketamine), a new nasal spray medication for the treatment of resistant depression.
The government has announced another increase in the cost of prescriptions for the public health service in England, from £ 8.80 to £ 9 as of 1 April this year. The cost will increase by 20 pence for each prescribed medicine, and the cost of wigs and fabric supports will also be increased in accordance with inflation.